Page results
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
This page is for patients who are having stereotactic ablative body radiotherapy (SABR) for lung cancer.
-
This information has been written to help you now that your radiotherapy treatment is finishing.
-
This booklet has been written for parents and carers whose child is having radiotherapy treatment to the neck, chest, abdomen, and pelvis.
-
This page is for parents and carers whose child is having radiotherapy treatment to the neck and chest.
-
This booklet has been written for parents and carers whose child is having radiotherapy treatment to the abdomen.
-
This page is to help prepare you and the family for your child’s radiotherapy treatment under a general anaesthetic.
-
This page is for parents and carers whose child is having radiotherapy treatment to a limb (arm or leg).
-
This information has been written for parents and carers whose child is having radiotherapy treatment to the whole lungs. The page explains the side effects your child may experience during and after treatment, and how best to cope with them.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the whole brain.
File results
-
FOI/2022/0169 - Strategic workforce plan for recruitment and retention of Allied Health Professions
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients